Nouscom

Series-B+
nouscom.com Biotech & Healthcare Basel, Switzerland Founded 2015 11-50
Total Funding $267.6M
Latest Round $135.0M Series-B+
Last Announced Oct 19, 2026
Investors 17 Backers
Decision Makers 6 Verified

About Nouscom

Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Basel, Switzerland
Year Founded 2015
Team Size 11-50
Tracked Since Oct 19, 2026

Web & Domain Identity

Official Website nouscom.com
Domain Registered Date Oct 28, 2014

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

6 Events
  1. Capital Raise

    Raised $135,040,000 · Series-B

    Backed by M Ventures, Revelation Partners

  2. Capital Raise

    Raised $72,000,000 · Series-B

    Backed by Andera Partners, Bpifrance

  3. Capital Raise

    Raised $46,940,000 · Series-B

    Backed by Abingworth, 5AM Ventures

  4. Capital Raise

    Raised $13,580,000 · Series-A

    Backed by EQT Life Sciences, Versant Ventures

  5. Milestone

    Company founded

    Basel, Switzerland

  6. Milestone

    Website domain registered

    nouscom.com

Investors & Backers

17
5AM Ventures
Abingworth
Andera Partners
Angelini Industries
Angelini Ventures
Bpifrance
CDP Venture Capital
EQT Life Sciences
European Investment Bank Group
Indaco Venture Partners
LSP BioVentures
M Ventures
Neva SGR
Panakes Partners
Revelation Partners
Versant Ventures
XGEN Venture

Funding History

4 Rounds
Series-B equity · Oct 19, 2026

Round backers: M Ventures, Revelation Partners, CDP Venture Capital, EQT Life Sciences, European Investment Bank Group, Indaco Venture Partners, Neva SGR, Panakes Partners, Versant Ventures, XGEN Venture

$135,040,000 manilatimes.net
Series-B equity · Nov 14, 2023

Round backers: Andera Partners, Bpifrance, M Ventures, 5AM Ventures, EQT Life Sciences, Indaco Venture Partners, Panakes Partners, Revelation Partners, Versant Ventures, XGEN Venture

Series-B equity · Jun 11, 2017

Round backers: Abingworth, 5AM Ventures, LSP BioVentures, Versant Ventures

Series-A equity · May 17, 2016

Round backers: EQT Life Sciences, Versant Ventures

$13,580,000 finsmes.com

Founders & Leadership

8

Cinzia Traboni

Founder

Work email & phone locked Unlock →

Elisa Scarduelli

Founder

Work email & phone locked Unlock →

Göran Ando

MD & Chairman

Work email & phone locked Unlock →

Loredana Siani

Technical Director for Development

Work email & phone locked Unlock →

Marina Udier

CEO

Work email & phone locked Unlock →

Patricia Delaite

CMO

Work email & phone locked Unlock →

Riccardo Cortese

Founder

Work email & phone locked Unlock →

Tiffany Muller

Chief Financial Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts